OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study

Detalles Bibliográficos
Autores principales: Mack, P.C., Gomez, J.C., Rodilla, A., Carreño, J.M., Hsu, C.-Y., Rolfo, C.D., Meshulami, N., Moore, A., Brody, R., King, J.C., Treatman, J., Lee, S., Raskin, A., Srivastava, K., Gleason, C.R., Tcheou, J., Bielak, D., Acharya, R., Gerber, D.E., Rohs, N., Henschke, C.I., Yankelevitz, D.F., Simon, V., Minna, J.D., Bunn, P.A., García- Sastre, A., Krammer, F., Shyr, Y., Hirsch, F.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Oa06 Impact of Covid-19 on Cancer Management and Protection from Vaccines, Monday, August 8, 2022 - 11:00 - 12:10
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452018/
http://dx.doi.org/10.1016/j.jtho.2022.07.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452018/
http://dx.doi.org/10.1016/j.jtho.2022.07.035

Ejemplares similares